Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
Yakult misses Q4 2026 earnings forecast significantly – shares fall
Yakult reported Q4 2026 earnings per share of ¥9.18 versus an expected ¥17.01, missing the forecast by 46.03%. Revenue was ¥114.65bn, slightly below the expected ¥115.01bn, and the stock fell 3.63% after the release. Declining domestic sales were partly offset by a recovery in overseas markets; management plans product innovation and efficiency measures to counter margin‑pressuring cost headwinds and a stagnant home market. » More on de.investing.com
YAKULT HONSHA with slightly lower revenue and increased annual EPS
YAKULT HONSHA reported quarterly EPS of 0.03 USD for the quarter ended March 31, 2026, compared with 0.020 USD a year earlier, and revenue of 730.7 million USD (prior year 744.2 million, -1.81%). For the fiscal year, EPS was 0.500 USD versus 0.490 USD in the prior year. Annual revenue fell to 3.23 billion USD from 3.28 billion USD in the prior year (-1.52%). » More on finanzen.net
Yakult beats EPS forecast, misses revenue expectations and shares fall
Yakult reported Q2 2025 EPS of ¥44.05 versus a forecast of ¥41.6, while revenue of ¥124.59bn missed the expected ¥127.91bn. The stock fell 5.04% after the results, closing at ¥2,582. Causes cited include a stronger yen, lower domestic sales volumes and higher costs; however, overseas business grew, notably in China and Vietnam. The company slightly trimmed its full-year forecast and is counting on marketing, new products and overseas expansion to drive a recovery in H2. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | Jun 2026 | |
|---|---|---|
| Revenue | 644.28M | 6.33% |
| Gross profit | 383.35M | 5.35% |
| Net profit | 72.69M | 6.24% |
| EBITDA | 92.87M | 14.45% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €4.3B |
Number of shares | 287.72M |
52-week high/low | €15.35 - €12.68 |
Dividend yield | 2.36% |
Dividends TTM | €0.36 |
Beta | 0.01 |
P/E ratio | 18.03 |
PEG ratio | 1.69 |
P/B ratio | 1.37 |
P/S ratio | 1.68 |
Company profile
Yakult Honsha Co.,Ltd. produziert und vertreibt Lebensmittel und Getränke, Kosmetika, Pharmazeutika und andere Produkte. Das Unternehmen ist in den Segmenten Nahrungsmittel und Getränke (Japan), Nahrungsmittel und Getränke (Amerika), Nahrungsmittel und Getränke (Asien und Ozeanien), Nahrungsmittel und Getränke (Europa), Pharmazeutika und Sonstige tätig. Das Unternehmen bietet fermentierte Milchgetränke, Säfte, Nudeln usw. über seine Heimliefer- und Einzelhandelskanäle an. Es bietet auch pharmazeutische Produkte wie Elplat, ein antineoplastisches Medikament, sowie generische Krebsmedikamente, einschließlich Gemcitabine Yakult, Capecitabine und Gefitinib Yakult Tabletten. Darüber hinaus bietet das Unternehmen Kosmetika an und betreibt die Tokyo Yakult Swallows, ein professionelles Baseballteam. Yakult Honsha Co., Ltd. wurde 1935 gegründet und hat seinen Hauptsitz in Tokio, Japan.
| Name | YAKULT HONSHA |
| CEO | Hiroshi Natsume |
| Headquarters | Tokyo,
ty Japan |
| Website | |
| IPO | 12/17/2010 |
| Employees | 29,618 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
Japan Exchange Group | 2267.T |
Pnk | YKLTF |
Frankfurt | YKH.F |
Düsseldorf | YKH.DU |
München | YKH.MU |
Discover assets
Shareholders of YAKULT HONSHA also invest in the following assets
